The DOI matches its Crossref record; 138 of the 140 references it cites were found in a registry or an index.
Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment
Open accessAbstract
The failure of a massive influx of tumor-infiltrating T lymphocytes to eradicate tumor cells in the tumor microenvironment is mainly due to the dysfunction of T cells hyporesponsive to tumors. T-cell exhaustion and senescence induced by malignant tumors are two important dysfunctional states that coexist in cancer patients, hindering effective antitumor immunity and immunotherapy and sustaining the suppressive tumor microenvironment. Although exhausted and senescent T cells share a similar dysfunctional role in antitumor immunity, they are distinctly different in terms of generation, development, and metabolic and molecular regulation during tumor progression. Here, we discuss the unique phenotypic and functional characteristics of these two types of dysfunctional T cells and their roles in tumor development and progression. In addition, we further discuss the potential molecular and metabolic signaling pathways responsible for the control of T-cell exhaustion and senescence in the suppressive tumor microenvironment. Understanding these critical and fundamental features should facilitate rethinking the unresponsiveness to current immunotherapies in clinical patients and lead to further development of novel and effective strategies that target different types of dysfunctional T cells to enhance cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“T cell senescence is irreversible, as opposed to their anergy and exhaustion, both of which are considered reversible [31, 38–40].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [39]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Research works printed but not linked: 2
- Fourcade, J. et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8(+) T cell dysfunction in melanoma patients. J. Exp. Med. 207, 2175–2186 (2010). · DOI · Paper page
- Brenchley, J. M. et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101, 2711–2720 (2003). · DOI · Paper page
Cited by
Sorted by citations
Items 301–388 of 388
Bugarín-Estrada, E. (2020) · Medicina Universitaria · doi:10.24875/rmu.m20000052
IMMUNE AGING AND SERIOUS CLINICAL IMPLICATIONS IN THE ELDERLY IN COVID-19
Barbosa, E. L., Dias, E. M., de Castro, L. L. V., & Brito, M. D. V. (2021) · RECISATEC - REVISTA CIENTÍFICA SAÚDE E TECNOLOGIA · doi:10.53612/recisatec.v1i5.53
Заботина, Т. Н., Ивановна, Ч. А., Анатольевна, Б. А., Захарова, Е. Н., Константиновна, Ш. Э., Шоуа, И. Б., Тамазиевич, Ц. В., Задеренко, И. А., & Григорьевна, К. З. (2022) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2022-21-2-47-55
Villarroya‐Beltri, C., Osório, A., Torres-Ruiz, R., Gómez-Sánchez, D., Trakala, M., Sánchez-Belmonte, A., Mercadillo, F., Pitarch, B., Hernández‐Núñez, A., Caturla, A. G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.08.503198
Phagocytic and chemiluminescent activity of blood neutrophils in patients with bladder cancer
Савченко, А. А., Zukov, R. A., Анатольевич, Ф. М., Слепов, Е. В., Belenyuk, V. D., Gvozdev, I. I., & Борисов, А. Г. (2022) · Russian Journal of Oncology · doi:10.17816/1028-9984-2021-26-2-39-48
Cheng, X. Y., Tan, X., Wang, W., Zhang, Z., Zhu, R., Wu, M., Li, M., Chen, Y., Liang, Z., Zhu, P., et al. (2023) · doi:10.1158/0008-5472.c.6514389
Karlsson, J. W., Sah, V. R., Bagge, R. O., Kuznetsova, I., Iqbal, M. M., Alsén, S., Stenqvist, S., Saxena, A., Ny, L., Nilsson, L. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.16.540908
Les lymphocytes T CD8+ ont-ils une capacité de réplication quasi-illimitée ?
Gensous, N., White, E., & Appay, V. (2023) · médecine/sciences · doi:10.1051/medsci/2023100
Senescent white blood cells in colorectal carcinoma patients
Thin, K. A. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.25
The T cell senescence in breast cancer
Denariyakoon, S. (2022) · doi:10.58837/chula.the.2022.26
Karlsson, J. W., Sah, V. R., Bagge, R. O., Iqbal, M. M., Alsén, S., Stenqvist, S., Saxena, A., Ny, L., Nilsson, L. M., & Nilsson, J. A. (2023) · eLife · doi:10.7554/elife.91705.1
He, T., Zhang, J., Zeng, L., Yin, Z., Shang, C., Yu, B., Zhang, X., Yang, X., Xue, L., & Guo, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3956824/v1
Fülöp, T., Cohen, A. A., Larbi, A., & Witkowski, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-55022-5_10
Cai, L., Chen, N., Qiu, X., Zeng, X., Huang, J., & Liu, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4021193/v1
Immune effector dysfunction signatures predict outcomes in patients with colorectal cancer
Tang, H., Wu, H., Jian, Y., Ji, T., Wu, Y., Wu, Y., Wang, P., & Cao, T. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111949
Xu, X., Wei, F., Xiao, L., Wu, R., Wei, B., Huang, S., Yi, J., & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611034
Xu, X., Wei, F., Xiao, L., Wu, R., Wei, B., Huang, S., Yi, J., & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611037
Xu, X., Wei, F., Xiao, L., Wu, R., Wei, B., Huang, S., Yi, J., & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611040
Xu, X., Wei, F., Xiao, L., Wu, R., Wei, B., Huang, S., Yi, J., & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611052
Xu, X., Wei, F., Xiao, L., Wu, R., Wei, B., Huang, S., Yi, J., & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611043
Xu, X., Wei, F., Xiao, L., Wu, R., Wei, B., Huang, S., Yi, J., & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611049
Xu, X., Wei, F., Xiao, L., Wu, R., Wei, B., Huang, S., Yi, J., & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611046
Karlsson, J. W., Sah, V. R., Bagge, R. O., Iqbal, M. M., Alsén, S., Stenqvist, S., Saxena, A., Ny, L., Nilsson, L. M., & Nilsson, J. A. (2023) · eLife · doi:10.7554/elife.91705.1.sa3
Karlsson, J., Sah, V. R., Bagge, R. O., et al. (2024) · eLife · doi:10.7554/elife.91705.2.sa2
Karlsson, J. W., Sah, V. R., Bagge, R. O., Kuznetsova, I., Iqbal, M. M., Alsén, S., Stenqvist, S., Saxena, A., Ny, L., Nilsson, L. M., et al. (2024) · eLife · doi:10.7554/elife.91705.2
Karlsson, J. W., Sah, V. R., Bagge, R. O., Kuznetsova, I., Iqbal, M. M., Alsén, S., Stenqvist, S., Saxena, A., Ny, L., Nilsson, L. M., et al. (2024) · eLife · doi:10.7554/elife.91705.2.sa0
Karlsson, J., Sah, V. R., Bagge, R. O., et al. (2024) · eLife · doi:10.7554/elife.91705.2.sa1
Reisser, Y., Hornung, F., Häder, A., Lauf, T., Nietzsche, S., Löffler, B., & Deinhardt‐Emmer, S. (2024) · eLife · doi:10.7554/elife.100433.1
Reisser, Y., Hornung, F., Häder, A., Lauf, T., Nietzsche, S., Löffler, B., & Deinhardt‐Emmer, S. (2024) · eLife · doi:10.7554/elife.100433.2
Zhou, E., Yuan, M., Zhong, J., & Xiao, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1435313
Chang, T., Chen, X., Yao, C., Li, Y., Li, L., Jin, Z., & Fan, J. (2024) · Aging Research · doi:10.26599/agr.2024.9340034
Hou, L., Li, Y., Xiong, X., Tanigawa, Y., Park, Y., Lenz, S. W., Grayson, A., Lee, J., Ryu, E., Olson, J. E., et al. (2025) · medRxiv · doi:10.1101/2025.03.17.25324124
Peng, L., Liang, Q., Rong, P., Zhang, S., Chen, H., Liu, H., Ma, X., & Wang, W. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251333295
Espinoza-de-León, G. N., Aguilar‐Lemarroy, A., Vega‐Magaña, N., Pereira-Suárez, A. L., Muñóz-Valle, J. F., Villegas-Pacheco, R., Jave‐Suárez, L. F., & García‐Chagollán, M. (2025) · Diagnostics · doi:10.3390/diagnostics15162019
Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines
Naigeon, M., Bitoun, S., Dugage, M. R., de Oliveira, C., Berthot, C., Besse, B., Marabelle, A., Danlos, F. X., Xavier Mariette, A., Chaput, N., et al. (2025) · Clinical & Experimental Immunology · doi:10.1093/cei/uxaf050
Mathematical Modeling on Immunotherapy and Its Application for Deriving Cancer Therapy
Padmanabhan, R., & Meskin, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00773-5_314
Васильевич, Б. Е., Vasilchenko, P. V., & Chernykh, E. R. (2025) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20250503
Beyond eradication: Therapeutic reprogramming strategies for cancer normalization (Review)
Shahiwala, A. (2025) · Oncology Reports · doi:10.3892/or.2025.9034
Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model
Spitzer, F. S., Camps, M. G. M., Britten, C. M., Vloemans, S. A., van Zeeburg, H. J. T., Melief, C. J. M., Arakelian, T., & OSSENDORP, F. A. (2025) · Nature Communications · doi:10.1038/s41467-025-67588-6
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24844701
Wang, Z. Z., Wen, X. L., Wang, N., Li, X. H., Guo, Y., Zhu, X., Fu, S., Xiong, F. F., Li, J., Wang, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24123720
Wang, Z. Z., Wen, X. L., Wang, N., Li, X. H., Guo, Y., Zhu, X., Fu, S., Xiong, F. F., Li, J., Wang, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24123729
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654485
Wang, Z. Z., Wen, X. L., Wang, N., Li, X. H., Guo, Y., Zhu, X., Fu, S., Xiong, F. F., Li, J., Wang, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24123726
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654461
Xu, X., Wei, F. Z., Xiao, L., Wu, R., Wei, B., Huang, S., 易俊林, & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611055
Wang, Z. Z., Wen, X. L., Wang, N., Li, X. H., Guo, Y., Zhu, X., Fu, S., Xiong, F. F., Li, J., Wang, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24123723
Wang, Z. Z., Wen, X. L., Wang, N., Li, X. H., Guo, Y., Zhu, X., Fu, S., Xiong, F. F., Li, J., Wang, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24123732
Xu, X., Wei, F. Z., Xiao, L., Wu, R., Wei, B., Huang, S., 易俊林, & Cui, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611058
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654482
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654479
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654470
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654467
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24844603
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654464
Xue, H., Lan, X., Xue, T., Tang, X., Yang, H., Hu, Z., Xu, N., & Xie, B. (2024) · Figshare · doi:10.6084/m9.figshare.25902278
Sun, Y., Lan, Q., Wang, Y., Xie, M., Wu, X., Lv, L., Xin, Q., Chen, J., Zhong, X., Yao, M., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01876-z
Wang, Y., Wang, Q., Xu, X., Yuan, H., Hu, Y., Feng, F., Liu, F., Jingwei, X. U. E., Liu, W., & Han, L. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114698
Dual roles of immunosenescence in cancer immunotherapy
Yu, Y., Sun, L., & Fan, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1779141
Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in Cancer
Wang, H.-J., Wen, X., Wu, Z., Wang, N., Fu, S.-H., Xiong, F.-F., Liang, J., Guo, D., Li, S., Shen, J., et al. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71117
Single cell multi-OMICS analysis of Treg biology in cancer
Richer, W. (2021) · theses.fr (ABES) · doi:10.70675/97f429e9z2993z4b78z88dezf46fae0d3a30
CD8+ T cell differentiation towards exhaustion in human cancer
Metoikidou, C. (2022) · theses.fr (ABES) · doi:10.70675/a9c41d93z98c7z40e0z80eczc8c778ad87ac
Anti-Tumor Immunity in Solid-Organ Transplant Recipients
Wong, J. S. L., Li, K. H. L., Li, B., Leung, R. C., Yap, D. Y. H., Chan, A. C. Y., Cheung, T.-T., & Yau, T. C. C. (2026) · Cancers · doi:10.3390/cancers18081216
Immune Aging Within the Tumor Microenvironment Predicts Survival in Lung Adenocarcinoma
Kim, T., Choi, H., Jang, T. W., & Oak, C. (2026) · Cancers · doi:10.3390/cancers18091343 · Cited by 1
Cao, Z., Su, F., Dun, X., Lu, Q., Xu, H., Su, P., Xue, Z., Wang, S., Yang, X., & Xu, H. (2026) · Discover Oncology · doi:10.1007/s12672-026-05112-y
Hou, L., Li, Y., Xiong, X., Tanigawa, Y., Park, Y., Lenz, S. W., Grayson, A., Lee, J., Ryu, E., Olson, J. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72543-0 · Cited by 1
Gaydosik, A. M., Wang, A., Das, J., Lapolla, B. A., Akilov, O. E., Geskin, L. J., & Fuschiotti, P. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015022
Okereke, J., Craig, A., Rojas, M., Degioanni, B., Lieberman, A. E., Sembrat, J., Evankovich, J., Bain, W., Bahudhanapati, H., Kass, D. J., et al. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.100387
Lau, L. S., Suarez, M., Berdalinova, A., Fan, R. Z., Shil, R. K., Souchak, J., Tieu, K., Posey, A. D., & Dimitroff, C. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146393
Blood transcriptome bridges orthogonal immunotypes and gut microbiome enterotypes in humans
Affaticati, F., Hà, M., Gehrmann, T., Boeck, I. D., Kuznetsova, M., Vandoren, R., Deuren, V. M. L. V., Alcedo, S., Jansens, H., Reu, H. D., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117752 · Cited by 5
Deciphering CD8+ T Cell Exhaustion in Human Cancers Through Single-Cell and Spatial Transcriptomics.
Gou, Z.-X., Huang, X.-J., & Zhao, X.-Y. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218767
Kamo, N., Soeda, S., Honda, T., & Fujimori, K. (2026) · Cancers · doi:10.3390/cancers18162530
Lei, Q., & Guo, X. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1912627
The senescence–immune axis as a target for combining immunotherapy and senotherapy
Saez‐Calazans, F., Grün, L. K., Stein, L. E., Barbé‐Tuana, F. M., & Filippi‐Chiela, E. C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103309
Zhou, B., Ju, X., Wang, J., Zhu, X., Yu, X., Wu, Y., Fu, Y., Wu, P., Song, L., & Zhang, Y. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2727809
Follicular lymphoma and the microenvironment: potential targets and biomarkers
Yang, Z., & Ansell, S. M. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2731956
Fu, J., Pei, S., Du, J., Deng, X., Wang, X., Li, T., Huang, H., Ye, J., Xu, J., Wang, X., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.09.004
Wu, J., Chen, S., Qiang, R., Cheng, L., Yao, M., Zhang, Z., Yu, X., Xu, J., & Zhang, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1938907
Senescence and tumor immunology: A multifaceted interplay of influence
Xie, Y., Zhang, J., Wang, S., Rao, D., Zhang, J., & Ao, Y. (2026) · iScience · doi:10.1016/j.isci.2026.117849
Immunophenotypic Profiles of General Chinese Population during Natural Aging
Li, Y., Wang, B., Han, X., Dang, J., Qiu, J., Liu, B., Wang, W., Zhou, F., Zhao, Y., Zhang, X., et al. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c03408
Self-citationBremm, M., Heinze, G., Schneeberger, L., Salzmann‐Manrique, E., Dehkordi, J. B., Peinelt, A., Kałwak, K., Mielcarek‐Siedziuk, M., Meisel, R., Beier, R., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1973579
Metadata
- Authors
- Zhao, Y., Shao, Q., & Peng, G.
- Affiliations
- Jiangsu University (CN)
- Saint Louis University (US)
- Corresponding author
- Peng, Guangyong
- Venue
- Cellular & Molecular Immunology
- Published
- 2019-12-18
- Volume
- 17
- Issue
- 1
- Pages
- 27-35
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- PMC
- PMC6952436
- OpenAlex
- W2995437528
- Cited by
- 382
- References
- 140
- Citations by year
- 2026: 39 · 2025: 90 · 2024: 70 · 2023: 59 · 2022: 61 · 2021: 45 · 2020: 18
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Cellular and Molecular Immunology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society (RSG-10-160-01-LIB)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- T cell exhaustion, T cell senescence, tumor-infiltrating T cells, tumor microenvironment, antitumor immunity, immunotherapy resistance, T cell metabolism, metabolic signaling pathways, cancer immunotherapy
- MeSH terms
- Animals, Humans, Immunotherapy, Neoplasms, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Cellular Senescence, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review